Skip to main content

PREvention of Late Stent Thrombosis by an Interdisciplinary Global European effort

Objetivo

According to the European Society of Cardiology there has been an increase in the life expectancy at the age of 65 of the European population from 15.0 to 17.0 years in the years since 1980. In the elderly, up to 50% of deaths are caused by cardiovascular diseases, the majority accounted for by coronary artery disease. The most effective treatment for obstructive coronary disease is percutaneous intervention with coronary stenting and fuelled by the increasing disease burden there has been a rapid increase in the number of percutaneous coronary intervention procedures in Europe from 184,000 in 1992 to 885,000 in 2004. If the rate of progression remains constant, the projected number of coronary intervention procedures per annum will be about 1.5 million by 2010, with a stenting rate of close to 100%. The principal safety issue with current coronary stenting procedures is late stent thrombosis which, with a case mortality rate approaching 50%, makes this problem a very significant European health issue.
The PRESTIGE project will result in significant improvement in prediction and prevention of late stent thrombosis by providing novel strategies that causally impede incident events without increasing the overall risk of bleeding. These goals will be achieved by a multidisciplinary consortium formed by world-leading EU-based specialists covering the requisite scientific skills and experience.
Since the first drug-eluting stent was introduced in 2002 the growth of this sector has been explosive. Forecasts predicted the potential for this market segment to exceed €4.6 billion by 2009. The economic impact of this very ambitious project will be to provide the European health industries with novel stent products and new imaging technologies to identify patients at-risk, as well as amended European treatment guidelines. The social impact will be, amongst others, a tremendous cost reduction for the public and private health insurance systems all over Europe.

Convocatoria de propuestas

FP7-HEALTH-2010-single-stage
Consulte otros proyectos de esta convocatoria

Coordinador

DEUTSCHES HERZZENTRUM MUNCHEN
Dirección
Lazarettstrasse 36
80636 Munich
Alemania
Tipo de actividad
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
Aportación de la UE
€ 1 182 400
Contacto administrativo
Per Larsen (Mr.)

Participantes (14)

AZIENDA OSPEDALIERA PAPA GIOVANNI XXIII
Italia
Aportación de la UE
€ 454 210
Dirección
Piazza Oms 1
24127 Bergamo
Tipo de actividad
Other
Contacto administrativo
Giulio Guagliumi (Dr.)
SAMODZIELNY PUBLICZNY ZAKLAD OPIEKI ZDROWOTNEJ SZPITAL UNIWERSYTECKI W KRAKOWIE
Polonia
Aportación de la UE
€ 58 200
Dirección
Ul. Kopernika 36
31 501 Krakow
Tipo de actividad
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
Contacto administrativo
Dariusz Dudek (Prof.)
STICHTING SINT ANTONIUS ZIEKENHUIS
Países Bajos
Aportación de la UE
€ 371 620
Dirección
Koekoekslaan 1
3435 CM Nieuwegein
Tipo de actividad
Research Organisations
Contacto administrativo
Jurrien Maria Ten Berg (Dr.)
UNIVERSITY OF LEICESTER
United Kingdom
Aportación de la UE
€ 669 364
Dirección
University Road
LE1 7RH Leicester
Tipo de actividad
Higher or Secondary Education Establishments
Contacto administrativo
Bikramjeet Singh (Mr.)
BENEDIKT-KREUTZ REHABILITATIONSZENTRUM FUER HERZ- UND KREISLAUFKRANKE BAD KROZINGEN EV

La participación finalizó

Alemania
Aportación de la UE
€ 121 200
Dirección
Suedring 15
79189 Bad Krozingen
Tipo de actividad
Research Organisations
Contacto administrativo
Christian Valina (Dr.)
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
Francia
Aportación de la UE
€ 990 356
Dirección
Rue De Tolbiac 101
75654 Paris
Tipo de actividad
Research Organisations
Contacto administrativo
Dina Falkenreck (Ms.)
RIGAS TEHNISKA UNIVERSITATE
Letonia
Aportación de la UE
€ 100 755
Dirección
Kalku Iela 1
1658 Riga
Tipo de actividad
Higher or Secondary Education Establishments
Contacto administrativo
Garry Kerch (Dr.)
KITOZYME SA
Bélgica
Aportación de la UE
€ 110 400
Dirección
Rue Haute Claire Parc Industriel 4
4040 Herstal
Tipo de actividad
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Contacto administrativo
Marie Hobe (Ms.)
HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH
Alemania
Aportación de la UE
€ 346 466,50
Dirección
Ingolstadter Landstrasse 1
85764 Neuherberg
Tipo de actividad
Research Organisations
Contacto administrativo
Juergen Ertel (Dr.)
KATHOLIEKE UNIVERSITEIT LEUVEN
Bélgica
Aportación de la UE
€ 711 270
Dirección
Oude Markt 13
3000 Leuven
Tipo de actividad
Higher or Secondary Education Establishments
Contacto administrativo
Walter Desmet (Prof.)
SERVICIO MADRILENO DE SALUD
España
Aportación de la UE
€ 121 440
Dirección
Plaza Carlos Trias Bertran 7
28020 Madrid
Tipo de actividad
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
Contacto administrativo
Fernando Alfonso (Dr.)
BIOTRONIK SE & CO. KG
Alemania
Aportación de la UE
€ 380 980
Dirección
Woermannkehre 1
12359 Berlin
Tipo de actividad
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Contacto administrativo
Alexander Rzany (Dr.)
NEOPLAS GMBH
Alemania
Aportación de la UE
€ 360 980
Dirección
Walther Rathenau Strasse 49A
17489 Greifswald
Tipo de actividad
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Contacto administrativo
Renate Schönebeck (Ms.)
UNIVERSITATS-HERZZENTRUM FREIBURG-BAD KROZINGEN GMBH
Alemania
Dirección
Sudring 15
79189 Bad Krozingen
Tipo de actividad
Research Organisations
Contacto administrativo
Gerhard Henninger (Mr.)